AD Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency SYM Q1 2026 Earnings EPS Misses by 80 but Stock Climbs on Strategic Momentum XPO Q1 2026 Earnings EPS Beats Estimates by 14 but Stock Falls on Revenue Concerns MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress MGM Q1 2026 Earnings EPS Miss Triggers Cautious Optimism as Shares Advance Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Wide Margin